TME Pharma N.V. (0N6A.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 6.63M |
| Enterprise Value | 5.55M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.01 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.40 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.64 |
| 52-Week Change 3 | -87.23% |
| S&P500 52-Week Change 3 | 24.96% |
| 52 Week High 3 | 1.6010 |
| 52 Week Low 3 | 0.1312 |
| 50-Day Moving Average 3 | 0.2291 |
| 200-Day Moving Average 3 | 0.3453 |
Share Statistics
| Avg Vol (3 month) 3 | 2.5k |
| Avg Vol (10 day) 3 | 5.78k |
| Shares Outstanding 5 | 41.51M |
| Implied Shares Outstanding 6 | 43.24M |
| Float 8 | N/A |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 0.00% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:100 |
| Last Split Date 3 | Jul 28, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -16,705.88% |
Management Effectiveness
| Return on Assets (ttm) | -90.92% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 17k |
| Revenue Per Share (ttm) | 0.00 |
| Quarterly Revenue Growth (yoy) | -50.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5.59M |
| Net Income Avi to Common (ttm) | -6.74M |
| Diluted EPS (ttm) | -1.3400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.25M |
| Total Cash Per Share (mrq) | 0.13 |
| Total Debt (mrq) | 1.17M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.86 |
| Book Value Per Share (mrq) | -0.02 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5.63M |
| Levered Free Cash Flow (ttm) | -3.57M |
© 2024 Yahoo. All rights reserved.